K Number
K111614
Device Name
CENTRICITY PERINATAL AND CENTRICITY INTENSIVE CARE
Date Cleared
2011-09-26

(110 days)

Product Code
Regulation Number
884.2740
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Centricity® Perinatal and Centricity Intensive Care is intended to be used as a data management tool with which a medical institution may define electronic forms to acquire device data and to document, annotate, display, store, print, export and retrieve patient/clinical practice information. This product is a primary tool for documentation as well as an adjunct tool for surveillance. The Centricity Perinatal and Centricity Intensive Care (CPN-CIC) is a clinical information system used to manage clinical data. The CPN-CIC may be used in the following clinical settings such as: - Labor and Delivery (Antepartum, Intrapartum) - Postpartum - Newborn Nursery - Critical Care Units (Neonatal Intensive Care, Adult Intensive Care) The CPN-CIC can be used in the hospitals, physician offices, and outpatient clinics where the system can accept and display data from the following sources such as: - Physiologic devices - External hospital and clinical information systems NOTE: This product does not replace clinical observation and evaluation of the patient at regular intervals by a qualified healthcare provider, who will make diagnoses and decide on treatments and/or interventions. Features of the product are intended to support clinical decision making and should be used in combination with other clinical inputs, such as real time patient observation, physical exam findings and information contained within other systems or recording tools. The product is not intended to be used as a primary monitoring or diagnostic device.
Device Description
The Centricity® Perinatal and Centricity Intensive Care is a data management tool. The basis for this submission is a modification to a legally marketed device. Both the proposed device intended use and indications for use statements are equivalent to that of the predicate device and have been reworded to improve clarity. Since 1999, Data Management Computer Systems and Technology have evolved. GEHC has modified the device by incorporating "state of the art" technology. The most significant changes being listed are: Overall product enhancements for security and privacy (to support HIPAA), interoperability enhancements, clinician notification enhancements, removal of some features only supplied on the old OS/2 platform version, keeping up with technology changes with respect to Windows Operating system, etc. On their own, none of these changes would have triggered a 510k submission. However, it was deemed important to clarify the Intended Use and Indications for use as well as to notify FDA of the current product state since many changes were made to keep up with the evolution of technology.
More Information

Not Found

Not Found

No
The document describes a data management system that has been updated with "state of the art" technology, primarily focusing on security, interoperability, and compatibility with modern operating systems. There is no mention of AI, ML, or related concepts in the intended use, device description, or the specific sections for AI/ML information.

No
The device is described as a "data management tool" and a "clinical information system" that supports clinical decision-making. It explicitly states, "The product is not intended to be used as a primary monitoring or diagnostic device." and "This product does not replace clinical observation and evaluation of the patient... who will make diagnoses and decide on treatments and/or interventions." These statements indicate it does not directly treat or diagnose patients, which would classify it as therapeutic.

No
The text explicitly states: "The product is not intended to be used as a primary monitoring or diagnostic device."

Yes

The device is described as a "data management tool" and a "clinical information system" that accepts and displays data from "physiologic devices" and "external hospital and clinical information systems." The description focuses on software enhancements (security, interoperability, notifications, OS compatibility) and does not mention any proprietary hardware components included with the device. While it interacts with hardware (physiologic devices), the device itself appears to be solely the software system for managing that data.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use/Indications for Use: The primary intended use is described as a "data management tool" for acquiring, documenting, displaying, storing, printing, exporting, and retrieving patient/clinical practice information. It's a clinical information system used to manage clinical data.
  • No mention of in vitro analysis: The description focuses on managing data from physiological devices and other information systems. There is no mention of analyzing samples (blood, urine, tissue, etc.) outside of the body, which is the core characteristic of an IVD.
  • Explicitly states it's not a primary monitoring or diagnostic device: The note clearly states the product is not intended to be used as a primary monitoring or diagnostic device. IVDs are used for diagnostic purposes.

The device is a clinical information system designed to support clinical decision-making by organizing and presenting patient data, but it does not perform the in vitro analysis required to be classified as an IVD.

N/A

Intended Use / Indications for Use

Centricity® Perinatal and Centricity Intensive Care is intended to be used as a data management tool with which a medical institution may define electronic forms to acquire device data and to document, annotate, display, store, print, export and retrieve patient/clinical practice information. This product is a primary tool for documentation as well as an adjunct tool for surveillance.

The Centricity Perinatal and Centricity Intensive Care (CPN-CIC) is a clinical information system used to manage clinical data. The CPN-CIC may be used in the following clinical settings such as:

  • Labor and Delivery (Antepartum, Intrapartum)
  • Postpartum
  • Newborn Nursery
  • Critical Care Units (Neonatal Intensive Care, Adult Intensive Care)

The CPN-CIC can be used in the hospitals, physician offices, and outpatient clinics where the system can accept and display data from the following sources such as:

  • Physiologic devices
  • External hospital and clinical information systems

NOTE: This product does not replace clinical observation and evaluation of the patient at regular intervals by a qualified healthcare provider, who will make diagnoses and decide on treatments and/or interventions. Features of the product are intended to support clinical decision making and should be used in combination with other clinical inputs, such as real time patient observation, physical exam findings and information contained within other systems or recording tools. The product is not intended to be used as a primary monitoring or diagnostic device.

Product codes

HGM 884.2740

Device Description

The Centricity® Perinatal and Centricity Intensive Care is a data management tool.
The basis for this submission is a modification to a legally marketed device. Both the proposed device intended use and indications for use statements are equivalent to that of the predicate device and have been reworded to improve clarity.
Since 1999, Data Management Computer Systems and Technology have evolved. GEHC has modified the device by incorporating "state of the art" technology. The most significant changes being listed are: Overall product enhancements for security and privacy (to support HIPAA), interoperability enhancements, clinician notification enhancements, removal of some features only supplied on the old OS/2 platform version, keeping up with technology changes with respect to Windows Operating system, etc. On their own, none of these changes would have triggered a 510k submission. However, it was deemed important to clarify the Intended Use and Indications for use as well as to notify FDA of the current product state since many changes were made to keep up with the evolution of technology.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Intended User: Qualified healthcare provider
Care Setting:

  • Labor and Delivery (Antepartum, Intrapartum)
  • Postpartum
  • Newborn Nursery
  • Critical Care Units (Neonatal Intensive Care, Adult Intensive Care)
  • Hospitals
  • Physician offices
  • Outpatient clinics

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

Centricity® Perinatal and Centricity Intensive Care [Formally known as Quantitative Sentinel (QS) System]

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 884.2740 Perinatal monitoring system and accessories.

(a)
Identification. A perinatal monitoring system is a device used to show graphically the relationship between maternal labor and the fetal heart rate by means of combining and coordinating uterine contraction and fetal heart monitors with appropriate displays of the well-being of the fetus during pregnancy, labor, and delivery. This generic type of device may include any of the devices subject to §§ 884.2600, 884.2640, 884.2660, 884.2675, 884.2700, and 884.2720. This generic type of device may include the following accessories: Central monitoring system and remote repeaters, signal analysis and display equipment, patient and equipment supports, and component parts.(b)
Classification. Class II (performance standards).

0

SEP 2 6 2011

Image /page/0/Picture/10 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined and enclosed within a circle. The logo is black and white.

GE Healthcare

Centricity® Perinatal and Centricity Intensive Care - 510(k) Premarket Notification

510(k) Summary

In accordance with 21 CFR 807.92 the following summary of information is provided:

Date:2011-Mar-04
Submitter:GE Healthcare - HCIT
540 W Northwest Highway
Barrington, IL, USA, 60010-3076
Primary Contact Person:Nicole Landreville
USA Premarket Regulatory Affairs Leader
GE Healthcare, QARA Regions - Americas
3000 North Grandview Boulevard #W450
Waukesha, WI, USA, 53188
T: (289) 208-2365
F: (414) 918-4498
Secondary Contact Person:Jeme Wallace
Director Regulatory Affairs
GE Heathcare IT
540 W Northwest Highway
Barrington, IL, USA, 60010-3076
T (847) 277-4468
F (847) 939-1446
Device/Trade Name:Centricity® Perinatal and Centricity Intensive Care
Common/Usual Name:Centricity® Perinatal and Centricity Intensive Care, CPN, Centricity
Perinatal
Classification Names:Perinatal monitoring system and accessories.
Product Code:HGM 884.2740
Predicate Device(s):Centricity® Perinatal and Centricity Intensive Care [Formally
known as Quantitative Sentinel (QS) System]

1

Image /page/1/Picture/2 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined and enclosed within a circle. The letters and the circle are black, contrasting with the white background. The logo is a well-known symbol associated with the General Electric company.

GE Healthcare

Centricity® Perinatal and Centricity Intensive Care - 510(k) Premorket Notification

| Device Description: | The Centricity® Perinatal and Centricity Intensive Care is a data
management tool. |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | The basis for this submission is a modification to a legally
marketed device. Both the proposed device intended use and
indications for use statements are equivalent to that of the
predicate device and have been reworded to improve clarity. |
| | Since 1999, Data Management Computer Systems and
Technology have evolved. GEHC has modified the device by
incorporating "state of the art" technology. The most significant
changes being listed are: Overall product enhancements for
security and privacy (to support HIPAA), interoperability
enhancements, clinician notification enhancements, removal of
some features only supplied on the old OS/2 platform version,
keeping up with technology changes with respect to Windows
Operating system, etc. On their own, none of these changes
would have triggered a 510k submission. However, it was
deemed important to clarify the Intended Use and Indications for
use as well as to notify FDA of the current product state since
many changes were made to keep up with the evolution of
technology. |

2

Image /page/2/Picture/2 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circular border. The letters and the border are in black, contrasting with the white background.

. "

GE Healthcare

Centricity® Perinatal and Centricity Intensive Care - 510(k) Premarket Notification

Intended Use:Centricity® Perinatal and Centricity Intensive Care is intended to be used as a data management tool with which a medical institution may define electronic forms to acquire device data and to document, annotate, display, store, print, export and retrieve patient/clinical practice information. This product is a primary tool for documentation as well as an adjunct tool for surveillance.
Indications for Use:The Centricity Perinatal and Centricity Intensive Care (CPN-CIC) is a clinical information system used to manage clinical data. The CPN-CIC may be used in the following clinical settings such as: Labor and Delivery (Antepartum, Intrapartum)PostpartumNewborn NurseryCritical Care Units (Neonatal Intensive Care, Adult Intensive Care)
The CPN-CIC can be used in the hospitals, physician offices, and outpatient clinics where the system can accept and display data from the following sources such as: Physiologic devicesExternal hospital and clinical information systems
NOTE: This product does not replace clinical observation and evaluation of the patient at regular intervals by a qualified healthcare provider, who will make diagnoses and decide on treatments and/or interventions. Features of the product are intended to support clinical decision making and should be used in combination with other clinical inputs, such as real time patient observation, physical exam findings and information contained within other systems or recording tools. The product is not intended to be used as a primary monitoring or diagnostic device.
Technology:The Centricity® Perinatal and Centricity Intensive Care employs the same fundamental scientific technology as its predicate devices.

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes coiled around it. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the caduceus symbol. The logo is black and white.

Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002

Ms. Jeme Wallace Director Regulatory Affairs GE Healtheare 540 W Northwest Highway BARRINGTON II. 60010

EP 2 6 2011

Re: K111614

Trade/Device Name: Centricity® Perinatal and Centricity Intensive Care Regulation Number: 21 CFR§ 884.2740 Regulation Name: Perinatal monitoring system and accessories Regulatory Class: H Product Code: HGM. MSX Dated: August 19, 2011 Received: August 23, 2011

Dear Ms. Wallace:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or 10 devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21; Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related

4

Page 2

adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.html for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Herbert P. Lerner, M.D., Director (Acting) Division of Reproductive, Gastro-Renal and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health.

Enclosure

5

510(k) Number (if known): K111614

Device Name:

Centricity® Perinatal and Centricity Intensive Care

Intended Use:

Centricity® Perinatal and Centricity Intensive Care is intended to be used in clinical departments of healthcare delivery systems such as Labor and Delivery, Postpatum Maternal Care, Newborn Nursery, critical care units including Neonatal Intensive Care Units (NCU), and may also be used in physician offices and outpatient clinics. This product is primarily intended to serve the purpose of electronic documentation of clinical data and is designed to serve the purpose
store and manage cinical data and is designed to accept, transfer, display, calculate, store and manage clinical data. System card is accept, fransfer, display, calcula
data from medical data. System cata and the user with the ability to acquire data from medical devices and to document, annotate, display, store, print, export and retrieve patient/clinical practice and to doomini, annotate, useplay, store, professional use only,

Indications for Use:

The Centricity Perinatal and Centricity Intensive Care (CPN-CIC) is a clinical information system used to manage clinical de Sentions intersive Care (CPN-ClC) is a clinical information system
as: as:

  • . Labor and Delivery (Antepartum, Intrapartum)
  • . Postpartum
  • Newborn Nursery .
  • Critical Care Units (Neonatal Intensive Care, Adult Intensive Care) .

The CPN-CIC can be used in the hospitals, physician offices, and outpatient clinics where the system can accept and display data from the following sources such as:

  • · Physiologic devices
  • · External hospital and clinical information systems

NOTE: This product does not replace clinical observation and evaluation of the patient at regular intervals by a qualified healthcare provider, who will make diagnoses and decident at regular and/or intentions. Features of the product and will have bland on treatments
should be used in combination with other alinied to support clinical decision making and should be used in continution with other clinical interior of the projection making a physical exam findings and information contained within other systems or recording tods. The product is not intended to be used as a primary monitoring or diagnostic device.

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (Part 21 CFR 801 Subpart C)

(Please do not WRITE BELOW THIS LINE - Continue on another page if needed)

Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Reproductive, Gastro-Renal, and
Urological Devices
510(k) NumberK111614